Jaguar Health Files 8-K with Financials and Exhibits
Ticker: JAGX · Form: 8-K · Filed: May 9, 2025 · CIK: 1585608
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
Jaguar Health filed an 8-K on 5/9/25 for financials & exhibits.
AI Summary
On May 9, 2025, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD Disclosure. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates that Jaguar Health, Inc. is providing updated financial information and exhibits to the SEC, which is standard procedure for public companies.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- May 9, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 200 Pine Street Suite 400 (address) — Principal Executive Offices
- San Francisco, California (location) — Principal Executive Offices City and State
- 415-371-8300 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing by Jaguar Health, Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits, along with a Regulation FD Disclosure.
On what date was this 8-K report filed?
The report was filed on May 9, 2025.
In which state is Jaguar Health, Inc. incorporated?
Jaguar Health, Inc. is incorporated in Delaware.
What is the address of Jaguar Health, Inc.'s principal executive offices?
The principal executive offices are located at 200 Pine Street Suite 400, San Francisco, California.
What is the telephone number for Jaguar Health, Inc.?
The telephone number, including area code, is (415) 371-8300.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding Jaguar Health, Inc. (JAGX).